Lara Osetinsky, M.D.
Otolaryngology Physician in Grand Rapids, Michigan.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,060 in Otolaryngology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Lara Osetinsky, M.D. reported a CMS MIPS final score of 80.9/100 - below the 83.5 national average - and filed 329 Medicare Part D claims in 2024.
- 80.9/100
- MIPS score · -3 vs avg
- 329
- Part D claims, 2024
- 88%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Lara Osetinsky, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1609283936), first enumerated 07/18/2014.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 329 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 80.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$46.89 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Michigan statewide board action statistics are published annually — these figures describe aggregate state activity, not Lara Osetinsky, M.D.'s individual license status. Verify directly with the state medical board.
Source: MI-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1609283936 · Otolaryngology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-INLINE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1609283936
- ENUM-MID 2014
- TAX-MID 11K Otolaryngology Physician
- MIPS-INLINE 80.9/100
- RX-LIGHT 329
- BOOK-THIN 298 in Michigan
- PHOTO-FINISH Keith Alexander, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Osetinsky · this…
Osetinsky · this provider
80.9 MIPS pts
- Glen Watkins, M.…
Glen Watkins, M.D.
80.9 MIPS pts
- Keith Alexander,…
Keith Alexander, MD
80.9 MIPS pts
- Gregory Osetinsk…
Gregory Osetinsky, MD
80.9 MIPS pts
- Ray Van Metre, M…
Ray Van Metre, MD
80.9 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Lara Osetinsky, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
81 ≥ 30th percentile 30% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Lara Osetinsky, M.D. sits
This provider among otolaryngology physician peers
Across the 3,290 otolaryngology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Lara Osetinsky, M.D. writes more Part D claims than 41% of them and scores higher on MIPS quality than 38% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one otolaryngology physician peer from a representative sample of 60; the gold marker is Lara Osetinsky, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Lara Osetinsky, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Lara Osetinsky, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Michigan
How Otolaryngology Physician compares to other specialties among Michigan providers
Otolaryngology Physician ranks #90 among Michigan's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Michigan provider total, by primary NUCC taxonomy. The highlighted bar is Otolaryngology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Lara Osetinsky, M.D.'s 2023 MIPS final score plotted against the Otolaryngology Physician national average
- MIPS Final Score
- 80.9/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Otolaryngology Physician US NPIs
80.9/100 MIPS final score - 2.6 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Otolaryngology Physician. Quality dim: 62.3. Cost dim: 74.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1609283936 |
|---|---|
| Specialty | Otolaryngology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 07/18/2014 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Lara Osetinsky, M.D.'s current license status, disciplinary history, and board certifications with the Michigan Department of Licensing and Regulatory Affairs in Michigan before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1609283936 is the unique 10-digit identifier CMS uses to link Osetinsky across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Lara Osetinsky, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$47
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Michigan MI-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Lara Osetinsky, M.D.. To verify Lara Osetinsky, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
12% brand-name claims vs 88% generic, on 329 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 365.633
- Total Day Supply
- 6,702
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $3K
- Generic Drug Cost
- $8K
- Opioid Claims
- 18 (5.5% rate)
- Antibiotic Claims
- 25
Patient Demographics
- Average Patient Age
- 74.1 years
- Avg HCC Risk Score
- 1.16
- Gender Split
- 58% female / 42% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Lara Osetinsky, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Clotrimazole-Betam…
Clotrimazole-Betamethasone
47 claims
- Ciprofloxacin-Dexa…
Ciprofloxacin-Dexamethasone
37 claims
- Mupirocin
Mupirocin
33 claims
- Ipratropium Bromide
Ipratropium Bromide
30 claims
- Ondansetron Odt
Ondansetron Odt
22 claims
- Oxycodone Hcl 18
Oxycodone Hcl
18 claims
- Albuterol Sulfate … 13
Albuterol Sulfate Hfa
13 claims
- Betamethasone Vale… 12
Betamethasone Valerate
12 claims
| Drug | Claims |
|---|---|
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 47 |
| Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth | 37 |
| Mupirocin | 33 |
| Ipratropium Bromide | 30 |
| Ondansetron Odt Ondansetron | 22 |
| Oxycodone Hcl | 18 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 13 |
| Betamethasone Valerate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngology Physician Overview
How Lara Osetinsky, M.D. fits within the Otolaryngology Physician landscape nationally.
Lara Osetinsky, M.D.'s 329 claims are below the specialty average of 536.
Nationwide Otolaryngology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Osetinsky, both outside Michigan so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (80.9 here).
Same NPPES enumeration year (2014)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Otolaryngology Physician Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Osetinsky.
One of 298 Otolaryngology Physician providers enrolled in Michigan, 5 are shown here.
Compare Otolaryngology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Lara Osetinsky, M.D.'s specialty? ▼
How much does Lara Osetinsky, M.D. prescribe under Medicare Part D? ▼
What is Lara Osetinsky, M.D.'s Medicare quality score? ▼
Where is Lara Osetinsky, M.D. located? ▼
What is Lara Osetinsky, M.D.'s NPI number? ▼
Does Lara Osetinsky, M.D. prescribe more brand-name or generic drugs? ▼
Does Lara Osetinsky, M.D. prescribe opioids? ▼
How many Otolaryngology Physician providers are there in the US? ▼
What drugs does Lara Osetinsky, M.D. prescribe most often? ▼
Does Lara Osetinsky, M.D. accept Medicare? ▼
How can I verify Lara Osetinsky, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.